Tag: CPH
Creso Pharma expands into Canada’s largest recreational cannabis market amid softening regulatory environment
Medicinal cannabis company Creso Pharma (ASX: CPH) has been riding the wave of loosening regulations relating to cannabis, with company also revealing it has expanded into Canada’s largest recreationa...
Creso Pharma continues to bask in strong anibidiol sales in Europe
Cannabis and hemp supplier Creso Pharma (ASX: CPH) has updated the market with sales statistics showing that its anibidiol hemp oil products have benefited over 100,000 dogs with the rising “humanisat...
PharmaCielo to acquire Creso Pharma for $122m
Canadian listed company PharmaCielo has launched a takeover bid for Creso Pharma (ASX: CPH), which Creso’s board endorses and values the company at A$122 million.
TSXV-listed PharmaCielo has a curr...
Creso Pharma granted licence to grow medicinal cannabis in Canada
The Canadian government has granted Australian company Creso Pharma (ASX: CPH) a licence to cultivate cannabis at a facility run by Creso’s wholly-owned subsidiary Mernova Medical in Nova Scotia.
C...
Creso Pharma signs Canadian medicinal cannabis supply deal
Medicinal cannabis developer Creso Pharma (ASX: CPH) has revealed the latest in a string of deals made since the start of the new year as it continues to build its global enterprise.
The company to...
Creso Pharma launches medical cannabis pain lozenge in Brazil
Medical cannabis developer Creso Pharma (ASX: CPH) has announced yet another foray into new markets following the launch of its cannaQIX 50 lozenge in South America’s most populous country, Brazil.
...
Creso Pharma signs UK-focused commercial agreement with Pharmacare Europe
Medical cannabis company Creso Pharma (ASX: CPH) has expanded its UK presence by signing a commercial agreement with UK-based Pharmacare Europe to market and distribute its proprietary cannaQIX produc...
Creso Pharma looks to the Middle East for medical cannabis commerce
Medical cannabis company Creso Pharma (ASX: CPH) has announced further progress on its path of gradual growth and expansion with this morning’s news that it has strengthened its market presence in Isr...
Creso Pharma JV set to launch cannabis beers into UK markets
An international beverage joint venture spearheaded by Australian-grown medical cannabis company Creso Pharma (ASX: CPH) has announced the imminent launch of a range of hemp-based beers and adult soft...
Creso Pharma aiming high for Israeli medical cannabis market
Biotech company Creso Pharma (ASX: CPH) is looking to continue its progress towards commercialising medicinal cannabis on a global scale, by signing a binding joint-venture agreement with Cohen Propag...
Australian pot stocks cultivating commercial progress in Canada
The onset of softening legislation towards cannabis in Canada and in other jurisdictions such as the US and Australia – both medicinally and recreationally – is providing a series of commercial opport...
Creso Pharma looks to establish early stake in reawakened medical cannabis industry
Barely a month after announcing its imminent launch of CannaQIX, biotech company Creso Pharma (ASX: CPH) is back in the headlines this week with the launch of cannaDOL, a nutraceutical product range a...
Creso Pharma records first revenues after launching cannaQIX and anibidiol
Biotech company Creso Pharma (ASX: CPH) has pleased shareholders by announcing the upcoming launch of a new product and booking its first revenues to the tune of CHF230,000 (A$311,940).
In partners...
Creso Pharma closes in on Colombian medicinal cannabis acquisition, firms up global presence
Creso Pharma (ASX: CPH) has reported its nearly completed due diligence to acquire Kunna Canada and its wholly-owned Colombian medicinal cannabis subsidiary Kunna SAS, with the transaction due to wind...
Creso Pharma to hit UK market with hemp-based cannaQIX products
Creso Pharma (ASX: CPH) will hit the United Kingdom market with its hemp-based cannaQIX®10 and 50 nutraceutical products after securing a distribution agreement with Precision Healthcare.
Based in ...
Creso Pharma shoulders into Latin America medicinal cannabis market with Kunna takeover
Creso Pharma (ASX: CPH) has shouldered into Latin America’s medicinal cannabis market with its proposed acquisition, worth about US$7.5 million, of Kunna Canada and its 100%-owned Colombian subsidiary...
Creso Pharma gains Swiss approval and distribution agreement to sell hemp-based stress pastilles
Medicinal cannabis and hemp company Creso Pharma (ASX: CPH) has secured regulatory compliance to sell its cannaQIX®10 throughout Switzerland and has inked a marketing and distribution agreement with S...
Creso Pharma teams up with experts to create cannabis and hemp-based alcohol drinks
Medicinal cannabis company Creso Pharma (ASX: CPH) has teamed up with Canada’s LGC Capital and United Kingdom-based Baltic Beer Company to develop cannabis and hemp-based alcoholic and non-alcoholic b...
Creso Pharma to sell cannabis-based lozenges in Australia
Days after teaming up with China-based hemp producer Zhejiang Kingdom Creative, Creso Pharma (ASX: CPH) has inked a deal with Australia-based Health House International, which will import and distribu...
Creso Pharma shoulders into China’s lucrative cannabis market
Creso Pharma (ASX: CPH) has shouldered its way into China’s medicinal cannabis and nutraceutical markets after entering a partnership and distribution agreement with hemp producer Zhejiang Kingdom Cre...
Creso Pharma on track to complete medical cannabis facility, sell edible cannabis products in Canada
Creso Pharma (ASX: CPH) is on track to complete its Canada-based medical cannabis growing facility by mid-2018 in time for new legislation allowing edible cannabis products to be sold in the country.
...
